Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in ChinaYuankai Shi, Jingwen Wang, Xiuhua Sun et al.|Journal of Hematology & Oncology|2017Cited by 256
Sequential Infusion of Mesenchymal Stem Cell for Graft-Versus-Host Disease Prevention in Haploidentical Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized Controlled Clinical TrialHan Yao, Xi Zhang, Ruihao Huang et al.|Journal of Clinical Oncology|2025Cited by 14
Interleukin-21 engineering enhances CD19-specific CAR-NK cell activity against B-cell lymphoma via enriched metabolic pathwaysBailin He, Na Xu, Jiaxu Wu et al.|Experimental Hematology and Oncology|2025Cited by 6
A Prospective, Multi-Center, Randomized, Controlled Clinical Trial to Explore the Role of Mesenchymal Stem Cells in Preventing Graft Versus Host DiseaseHan Yao, Xi Zhang, Xiaoqi Wang et al.|Blood|2023Cited by 1